^1. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136: 2318-326.

^2. Toda A, MD. LASIK and Dry Eye. Comprehensive Ophthalmology Update. August 2007; 8(2):79-85.

^3. Noecker RJ. Comparison of initial treatment response to two enhanced-viscosity artificial tears. Eye and Contact Lens. 2006; 32(3): 148-152.

^4. Simmons P, Vehige J. The effect of artificial tear composition on tear film break-up time. Optom Vis Sci. 2004;81(12s):235.

^5. Christensen M, Stein J, Stone R, Meadows D. Evaluation of tear film break-up time extension by artificial tears in Dry Eye patients. Optom Vis Sci. 2003;80(21s):106

^6. Brennan NA, Chantal Coles M-L, Simmons P, Vehige J. Tear thickening and duration of effect with different lubricant eyedrops. Optom Vis Sci. 2004;81(12s):234.

^7. Garrett G, et al. CMC binds to human corneal epithelial cells through glucose-binding sites and stimulates cell migration. Presented at: Annual Meeting of the American     Academy of Optometry; December 2006; San Diego, Calif.

^8. Sharma A. Surface-chemical pathways of the tear film breakup. Does corneal mucus have a role? Adv Exp Med Biol. 1998; 438; 361-370.

^9. Noecker RJ. Eye drops: Purite may be gentler preservative for lubrication solutions. Stabilized oxychloro complex shows no cytotoxic effects to the corneal surface.
   Ophthalmol Times. 2001;26(21):72-75.

^10. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther. 2001;18;205-215.

^11. Prather W, et al. Clinical Performance of a New Mid-Viscosity Artificial Tear for Dry Eye Treatment, ARVO Annual Meeting, May 2003, #3152.

^12. Chantal Coles M-L, Brennan NA, Shuley V, et al. The influence of lens conditioning on signs and symptoms with new hydrogel contact lenses.
     Clin Exp Optom. 2004;87:367-371.

^13.Way WA, et al. Purite^® as a nondisruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives. Presented at the
     Association for Research in Vision and Ophthalmology (ARVO), 2001 and published abstract reference: Investigative Ophthalmology and Visual Science 2001;42(4):S39.

^14. Way WA, et al. Purite® as a nondisruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives. Presented at the
     Association for Research in Vision and Ophthalmology (ARVO), 2001 and published abstract reference: Investigative Ophthalmology and Visual Science 2001;42(4):S39.

^15. Corfield AP, Shukla AK. Mucins: Vital Components of the Mucosal Defensive Barrier. International Scientific Communications, Inc. February 2003; GPT:20-23.

Systane^® is a registered trademark of Alcon Laboratories, Inc.